Toro Labs Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, extensively researched for metabolic regulation, weight management and glucose control, supplied as a 60mg lyophilised vial. HPLC tested and authenticated on every batch.
Key details
- 60mg lyophilised peptide, single vial
- Dual receptor agonist: GLP-1 and GIP
- Batch tested via HPLC analysis
- Toro Labs authenticated product
Research benefits
- Studied for significant weight reduction
- Supports blood glucose and insulin sensitivity
- May improve cardiovascular markers
- Leading compound in obesity and metabolic research
Suggested protocol
- Starting dose 2.5mg to 5mg per week
- Subcutaneous administration
- Gradual titration recommended in research settings
- Reconstitute with bacteriostatic water before use
About Tirzepatide 60mg
Tirzepatide 60mg is a synthetic dual GIP and GLP-1 receptor agonist peptide, supplied as a lyophilised powder. It carries a strength of 60mg. It is part of the Toro Labs range, our own house brand, and Express Peds is an official re-seller. Ordered before 2pm Monday to Friday it is dispatched the same day from the UK, sent Royal Mail Tracked 24 in plain unbranded packaging.


